Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cashflow Statement

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹338 Cr₹248 Cr₹302 Cr₹157 Cr₹104 Cr
Adjustment ₹74 Cr₹35 Cr₹57 Cr₹42 Cr₹32 Cr
Changes In working Capital ₹-111 Cr₹-111 Cr₹-132 Cr₹59 Cr₹-82 Cr
Cash Flow after changes in Working Capital ₹300 Cr₹172 Cr₹227 Cr₹258 Cr₹54 Cr
Cash Flow from Operating Activities ₹237 Cr₹99 Cr₹179 Cr₹233 Cr₹27 Cr
Cash Flow from Investing Activities ₹-259 Cr₹-84 Cr₹-45 Cr₹-60 Cr₹-13 Cr
Cash Flow from Financing Activities ₹198 Cr₹80 Cr₹-15 Cr₹-114 Cr₹-21 Cr
Net Cash Inflow / Outflow ₹176 Cr₹94 Cr₹118 Cr₹60 Cr₹-6.86 Cr
Opening Cash & Cash Equivalents ₹206 Cr₹112 Cr₹94 Cr₹34 Cr₹40 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹0.00 Cr----
Closing Cash & Cash Equivalent ₹382 Cr₹206 Cr₹212 Cr₹94 Cr₹33 Cr

Compare Cashflow Statement of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,563.9 Cr -4.3% 15.5% 114.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹364,831.0 Cr -0.1% -2.8% 50.3% Stock Analytics
CIPLA ₹113,471.0 Cr 4.5% -3.1% 52.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,713.0 Cr 4.6% 1.4% 22.2% Stock Analytics
DIVIS LABORATORIES ₹101,960.0 Cr 4.7% 10.8% 18.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,687.8 Cr 3.1% -4.1% 80.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.3%

15.5%

114.6%

SENSEX

1.3%

2.6%

24%


You may also like the below Video Courses